Location History:
- Langebuuch, DE (1999)
- Langebüuch, DE (2003)
Company Filing History:
Years Active: 1999-2003
Title: Wilfried Thiel: Innovator in Pharmaceutical Chemistry
Introduction
Wilfried Thiel is a notable inventor based in Munich, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative patents. With a total of 2 patents, Thiel's work focuses on the development of novel compounds that have potential applications in medicine.
Latest Patents
Thiel's latest patents include modifications of the compound 2-amino-4-(4-fluorobenzylamino)-1-ethoxycarbonylaminobenzene. This invention relates to novel modifications of the compound and processes for their preparation. The modifications are aimed at enhancing the compound's efficacy in pharmaceutical compositions.
Career Highlights
Wilfried Thiel is associated with Asta Medica, Aktiengesellschaft, where he has been instrumental in advancing research and development in pharmaceutical products. His expertise in chemistry and innovation has positioned him as a key figure in his field.
Collaborations
Thiel has collaborated with notable colleagues such as Peter Meisel and Karl-Friedrich Landgraf. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in pharmaceutical research.
Conclusion
Wilfried Thiel's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an innovator in the industry. His work continues to influence the development of new medical compounds that may benefit healthcare in the future.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.